Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Any KLY news from an independent source?
View:
Post by Scotty on Sep 08, 2020 9:55pm

Any KLY news from an independent source?

Or just from the company itself or it's affiliates?
Comment by losingmyshirt on Sep 09, 2020 9:31am
Scotty, same as always. No news from anyone other than the pumpers and the pumper site Kalyteran.
Comment by Scotty on Sep 09, 2020 10:37am
I figured as much. But hey, maybe all bs being spewed will convince some suckers to buy this snake oil so we can get out with only a reasonable loss.
Comment by JMark80 on Sep 09, 2020 6:24pm
Would be nice, but won't happen. 
Comment by Dude51 on Sep 09, 2020 7:55pm
Scotty, Scotty and Losingmyshit, when you all read the previous post about Salzman Team and the level of experience and educational back grounds for this company and you read what Andrew Salzman has done with his life and realize, glad he likes KLY deal, it's awesome. What did you guys do today? Read any books, with out pictures? I have to wonder, do you know how to read? Do you think Salzman, ...more  
Comment by Scotty on Sep 09, 2020 8:52pm
Wow, must have hit a nerve lol. You know what, you're 100% correct! This is like winning the lottery! You should invest everything you have into it as soon as it opens! Take out loans, borrow from friends and family,  remorgage your house! You can't let this opportunity pass by! You should keep raising the price up too! What does it matter right? This is going to $20 anyway.
Comment by JMark80 on Sep 09, 2020 10:09pm
Not sure how long you've been here, but there were quite a few pumping this when it was 10x the price. Penny was the most annoying pumper, before he was the most annoying basher. I haven't seen him in a while, maybe he's dead?
Comment by Hockydad on Sep 09, 2020 10:27pm
This post has been removed in accordance with Community Policy
Comment by JMark80 on Sep 09, 2020 10:07pm
Salzman is involed with several companies, and was previous CEO of Kalytera. Aren't you suspicious that Salzman group only has one compound in its pipeline? I don't think this will go through anyway. Last funding was for a small amount and was undersubscribed at $.015 with warrant. If it does, look out because there will be well over a billion shares fully diluted.
Comment by JMark80 on Sep 09, 2020 10:13pm
Nobody will touch this. Kaly had to pay Salzman in shares for phase 2, which Salzman dumped into open market. Last undersubscribed financing was directed at stockhouse members! How pathetic!
Comment by Hockydad on Sep 09, 2020 11:01pm
This post has been removed in accordance with Community Policy
Comment by Dude51 on Sep 10, 2020 3:05am
again just one link bashers, here is my link to the truth. lol I guess its just smart people that can read and comprehend. We have a winner, just have to be patient and ignore the bashers, again bashers one link to prove this is a scam. BARDA I would take their assesment over Salzman long before your dingus delusions.... "Development of R-107 for CILI funded under contract with BARDA ...more  
Comment by Scotty on Sep 10, 2020 5:40am
Yes we understand that KLY news releases are basically holy scripture to you. Those of us living in the real world and have critical thinking skills just want as much of our money back as possible. Again, is there any "truth" out there that doesn't come directly from this company or its affiliates?
Comment by Dude51 on Sep 10, 2020 9:59am
Coming from a loser who thinks 5G is somehow a death ray.Why did you invest in the first place? Invest then bash, good plan.
Comment by Scotty on Sep 10, 2020 10:21am
I, like most of the other "bashers" here,  was scamned by the GVHD research. We "acquired" Talent, which had basically 1 promising asset, publicly funded the research, then handed it back consequence free but with KLY massively diluted and our share price annihilated. Sound familiar?
Comment by JMark80 on Sep 10, 2020 11:31am
R107 is gonna make all us bruhs rich.
Comment by losingmyshirt on Sep 10, 2020 4:00pm
Oh my. So the "bruhs" are going to get rich. That thought must be keeping all 4 of the Followers on the Kalyteran website awake at night planning on where to spend their fortunes  while they rub themselves to sleep. 
Comment by Hockydad on Sep 11, 2020 2:45pm
This post has been removed in accordance with Community Policy
Comment by bud13 on Sep 10, 2020 4:07pm
to b honest. I can't not disagree with this post.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities